Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Las Palmas de Gran Canaria
Clinical trial register · Spain

Clinical Trials in Las Palmas de Gran Canaria, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5875 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5875
Studies in scope
all four open statuses
3096
Recruiting now
open to new participants
1137
Lead sponsors
across recruiting studies
Top sites
Barcelona 113 Madrid 106 Seville 47 Valencia 38 L'Hospitalet de Llobregat 35
Narrow the registerReset
Recruitment status
Phase
Target enrolment
to

Trials with a site in Las Palmas de Gran Canaria

13 of 5875 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Recruiting
Merck Sharp & Dohme LLC
Phase 3
590
Badalona, Santander, Las Palmas de Gran Canaria, Madrid, Barcelona, Seville
2026-04-23
Recruiting
Merck Sharp & Dohme LLC
Phase 3
400
Las Palmas de Gran Canaria, Girona, Majadahonda, Barcelona, Madrid, Málaga, Seville
2026-03-18
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
170
Logroño, Las Palmas de Gran Canaria, Barcelona, Madrid
2026-01-29
Recruiting
Merck Sharp & Dohme LLC
Phase 3
477
Badalona, Santander, Las Palmas de Gran Canaria, Oviedo, Barcelona, Madrid, Seville, Valencia
2025-07-16
Recruiting
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
NCT06833073Urinary Bladder Neoplasms, Non-Muscle Invasive Bladder Neoplasms, Carcinoma in Situ
Merck Sharp & Dohme LLC
Phase 2
308
Sabadell, Las Palmas de Gran Canaria, Madrid, Seville
2025-03-11
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,046
Seville, L'Hospitalet de Llobregat, Barakaldo, Las Palmas de Gran Canaria, Majadahonda, Gijón, Alicante, Barcelona
2025-01-27
Recruiting
Merck Sharp & Dohme LLC
Phase 3
851
Santiago de Compostela, Las Palmas de Gran Canaria, Málaga, Barcelona, Madrid, Seville
2024-06-10
Recruiting
Merck Sharp & Dohme LLC
Phase 3
780
L'Hospitalet de Llobregat, Santiago de Compostela, Las Palmas de Gran Canaria, Pozuelo de Alarcón, Barcelona, Madrid
2024-04-03
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,314
Sabadell, Barcelona, Girona, A Coruña, Las Palmas de Gran Canaria, Pozuelo de Alarcón, Burgos, Málaga
2023-12-18
Active, closed
Merck Sharp & Dohme LLC
Phase 3
556
Barcelona, Las Palmas de Gran Canaria, Pozuelo de Alarcón, Madrid, Málaga
2023-11-12
Active, closed
Merck Sharp & Dohme LLC
Phase 3
808
Badalona, Manresa, Girona, Santiago de Compostela, Las Palmas de Gran Canaria, Oviedo, Valencia, Barcelona
2021-04-21
Active, closed
Merck Sharp & Dohme LLC
Phase 3
797
Badalona, L'Hospitalet de Llobregat, Girona, Las Palmas de Gran Canaria, Barcelona, Madrid, Seville
2018-04-24
Rows per page Showing 1–13 of 13
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-spain/city/las-palmas-de-gran-canaria

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,875 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 13 of those studies with a site in Las Palmas de Gran Canaria that also match the filters currently applied.

How many clinical trials are recruiting in Las Palmas de Gran Canaria?

10 of the 13 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 3 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Las Palmas de Gran Canaria), 13 studies
PhaseStudiesRecruitingShare
Phase 311884.6%
Phase 1/2117.7%
Phase 2117.7%

Most active sponsors

Lead sponsors with the most studies (Las Palmas de Gran Canaria)
Lead sponsorStudiesRecruiting
Merck Sharp & Dohme LLC1310
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.